Axonics Modulation Technologies

Axonics Modulation Technologies is one of the...

• Russell 3000.

Axonics Modulation Technologies is a company listed under the stock ticker AXNX (US).

Acquisition, funding and merger involving Axonics Modulation Technologies.

• Boston Scientific has announced the acquisition of Axonics Modulation Technologies  (posted on January 9 2024).

View the org chart displaying its 17 main executives

Most searched biographies at Axonics Modulation Technologies

• Raymond Cohen, Chief Executive Officer and Director
• David Demski, Director
• Jane Kiernan, Director

Popular executive movements at Axonics Modulation Technologies

• Kari Keese who is Vice President of Finance and Accounting, will be promoted to President and Chief Financial Officer on Oct. 2, 2023  (posted on August 22 2023).
• Dan Dearen, President and Chief Financial Officer, will retire on Oct. 2, 2023  (posted on August 22 2023).

Create your alert
to follow the executive moves at Axonics Modulation Technologies.

Axonics Modulation Technologies has 986 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).

Popular M&A news in Medical Equipment

• Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
• Johnson & Johnson has announced the acquisition of Shockwave Medical  (posted on April 6 2024).
• Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).

Popular contacts in Medical Equipment

• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific
• Don Abbey - Executive Vice President, Global Business Services, Information Technology, Quality and Regulatory Affairs at DexCom
• Robert Rosenthal - Director at Bruker

Learn more about the Medical Equipment industry >

Press releases by Axonics Modulation Technologies

• Axonics® Announces Pricing of Public Offering of Common Stock | Axonics, Inc.
• Axonics® Announces Proposed Public Offering of Common Stock | Axonics, Inc.
• Axonics® Reports Second Quarter 2022 Financial Results | Axonics, Inc.
• Axonics® to Report Second Quarter 2022 Financial Results on August 1 | Axonics, Inc.
• Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator | Axonics, Inc.
• Axonics® Reports First Quarter 2022 Financial Results | Axonics, Inc.
• Axonics® to Participate in BofA Securities 2022 Healthcare Conference | Axonics, Inc.
• Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System | Axonics, Inc.
• Axonics® to Report First Quarter 2022 Financial Results on May 5 | Axonics, Inc.
• Axonics® Launches Direct to Consumer Television Advertising Campaign | Axonics, Inc.
• View more press releases Close

Social media about Axonics Modulation Technologies

• Axonics Modulation Technologies on Wikipedia, Google News & Yahoo Finance
• Axonics Modulation Technologies on LinkedIn, Twitter & YouTube

Contact by email its executives including David Demski

Call Axonics Modulation Technologies at +1 949...

View the org chart

Register to receive your alert

Report an error